Skip to Main Content

Paper Details

Cardiovascular consequences of discontinuing low-dose rivaroxaban in people with chronic coronary or peripheral artery disease.
Heart
4
2021
People, aspirin, cardiovascular death, chronic coronary or peripheral artery disease, ischaemic stroke, myocardial infarction, participants, patients, people, person, rivaroxaban, stroke
Author NameAffiliation
Deepak L BhattBrigham and Women's Hospital Heart & Vascular Center and Harvard Medical School
Keith A A FoxUniversity of Edinburgh
Salim YusufPopulation Health Research Institute, Hamilton Health Sciences/McMaster University
  • 1 - 3

Datasets

Release 1.2